Discover 483 paid clinical trials in Warwick, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 483
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Providence RI, Boston MA, New Haven CT, New York NY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT03972657
Phase1, Phase2, Recruiting
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
for
Neoplasms, Child, Adolescent
Location: Providence RI, New York NY, Washington D.C. DC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 1 - 39
Code: NCT05999994
Phase2, Recruiting
A New Clinical Model for the Engagement of Latinx Youth With Suicidal Behavior
Location: Providence RI, Philadelphia PA, Durham NC, Chicago IL,
Sponsor: NICHD Pelvic Floor Disorders Network
Sex: Female
Age: 21+
Code: NCT06480227
Recruiting
Accelerometer Measured Early Recovery After Prolapse Surgery
for
Pelvic Organ Prolapse, Pelvic Organ Prolapse (POP),
Location: Providence RI, Philadelphia PA, Durham NC, Chicago IL,
Sponsor: NICHD Pelvic Floor Disorders Network
Sex: Female
Age: 18 - 70+
Code: NCT07218016
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Optimization of a Behavioral Intervention to Increase Physical Activity in Older Adults Living With HIV
for
Hiv, Physical Inactivity, Aging
Location: Providence RI, Minneapolis MN
Sponsor: Butler Hospital
Sex: All
Age: 50+
Code: NCT05752500
Recruiting
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)